About BeaconCure
BeaconCure is a company based in Tel Aviv (Israel) founded in 2016. BeaconCure has raised $40.92 million across 4 funding rounds from investors including NewVale Capital. BeaconCure offers products and services including Verify. BeaconCure operates in a competitive market with competitors including Definitive Healthcare, ESO, Molecular Connections, Collaborative Drug Discovery and Borderless Access, among others.
- Headquarter Tel Aviv, Israel
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$40.92 M (USD)
in 4 rounds
-
Latest Funding Round
$14.99 M (USD), Series C
Jan 03, 2025
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BeaconCure
BeaconCure offers a comprehensive portfolio of products and services, including Verify.
Automates validation of clinical trial outputs using ML for accuracy.
People of BeaconCure
Unlock access to complete
Funding Insights of BeaconCure
BeaconCure has successfully raised a total of $40.92M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $14.99 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BeaconCure
BeaconCure has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include NewVale Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
NewVale Capital is focused on life sciences investment.
|
Locked | Locked | Locked |
Investor details for BeaconCure
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BeaconCure
Investment portfolio details for BeaconCure
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BeaconCure
Detailed financials for BeaconCure
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Beaconcure Comparisons
Peer comparison for BeaconCure
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BeaconCure
BeaconCure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Definitive Healthcare, ESO, Molecular Connections, Collaborative Drug Discovery and Borderless Access, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Offers market intelligence and data analytics for healthcare providers and physicians
|
|
| Locked | Locked | Locked |
EHR platform for emergency services is provided.
|
|
| Locked | Locked | Locked |
Databases and analytics for drug discovery are provided.
|
|
| Locked | Locked | Locked |
Biological and chemical data are managed securely in a database.
|
|
| Locked | Locked | Locked |
Analytics-driven sampling suite for healthcare market research is offered.
|
|
| Locked | Locked | Locked |
Patient-level healthcare data solutions are provided to pharmaceutical sectors.
|
Detailed competitors of BeaconCure
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Beaconcure
Complete news archive for BeaconCure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BeaconCure
BeaconCure was founded in 2016 and raised its 1st funding round 5 years after it was founded.
BeaconCure is headquartered in Tel Aviv, Israel.
BeaconCure is a funded company, having raised a total of $40.92M across 4 funding rounds to date.
BeaconCure was founded in 2016 in Tel Aviv, Israel, within the healthcare sector. Software for data analytics and validation is developed to support regulatory submissions for drug and vaccine development. Artificial intelligence is utilized to extract and analyze data from tables and text, while inconsistencies are tracked to ensure submission accuracy. Operations focus on identifying critical challenges in regulatory approvals.
BeaconCure's top competitors include Definitive Healthcare, ESO and BioCentury.
BeaconCure offers Verify.
BeaconCure has 1 investor. Key investors include NewVale Capital.